WallStreetZenWallStreetZen

NASDAQ: TLPH
Talphera Inc Stock

$0.98+0.00 (+0%)
Updated Jun 12, 2024
TLPH Price
$0.98
Fair Value Price
-$0.39
Market Cap
$16.70M
52 Week Low
$0.43
52 Week High
$1.61
P/E
-1.16x
P/B
1.02x
P/S
39.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$651.00k
Earnings
-$14.20M
Gross Margin
100%
Operating Margin
-2,111.06%
Profit Margin
-2,181.1%
Debt to Equity
0.76
Operating Cash Flow
-$15M
Beta
1.18
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

TLPH Overview

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TLPH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TLPH ($0.98) is overvalued by 352.38% relative to our estimate of its Fair Value price of -$0.39 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TLPH ($0.98) is not significantly undervalued (352.38%) relative to our estimate of its Fair Value price of -$0.39 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TLPH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TLPH due diligence checks available for Premium users.

Be the first to know about important TLPH news, forecast changes, insider trades & much more!

TLPH News

Valuation

TLPH fair value

Fair Value of TLPH stock based on Discounted Cash Flow (DCF)
Price
$0.98
Fair Value
-$0.39
Undervalued by
351.61%
TLPH ($0.98) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TLPH ($0.98) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TLPH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TLPH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.16x
Industry
1.26x
Market
30.03x

TLPH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.02x
Industry
2.18x
TLPH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TLPH's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.0M
Profit Margin
0%
TLPH's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
TLPH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$28.8M
Liabilities
$12.4M
Debt to equity
0.76
TLPH's short-term assets ($19.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TLPH's short-term assets ($19.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TLPH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TLPH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.9M
Investing
-$2.7M
Financing
$12.0M
TLPH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TLPH vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
TLPH$16.70M+0.72%-1.16x1.02x
AYTU$16.31M-3.43%-1.20x0.53x
KALA$17.32M-0.49%-0.41x2.60x
RDHL$15.68M-0.24%0.10x7.58x
FLGC$14.35M+0.90%-0.15x4.57x

Talphera Stock FAQ

What is Talphera's quote symbol?

(NASDAQ: TLPH) Talphera trades on the NASDAQ under the ticker symbol TLPH. Talphera stock quotes can also be displayed as NASDAQ: TLPH.

If you're new to stock investing, here's how to buy Talphera stock.

What is the 52 week high and low for Talphera (NASDAQ: TLPH)?

(NASDAQ: TLPH) Talphera's 52-week high was $1.61, and its 52-week low was $0.43. It is currently -38.94% from its 52-week high and 131.29% from its 52-week low.

How much is Talphera stock worth today?

(NASDAQ: TLPH) Talphera currently has 16,992,977 outstanding shares. With Talphera stock trading at $0.98 per share, the total value of Talphera stock (market capitalization) is $16.70M.

Talphera stock was originally listed at a price of $91.00 in Feb 11, 2011. If you had invested in Talphera stock at $91.00, your return over the last 13 years would have been -98.92%, for an annualized return of -29.41% (not including any dividends or dividend reinvestments).

How much is Talphera's stock price per share?

(NASDAQ: TLPH) Talphera stock price per share is $0.98 today (as of Jun 12, 2024).

What is Talphera's Market Cap?

(NASDAQ: TLPH) Talphera's market cap is $16.70M, as of Jun 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Talphera's market cap is calculated by multiplying TLPH's current stock price of $0.98 by TLPH's total outstanding shares of 16,992,977.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.